Wednesday, December 3, 2014

Funding Opportunity: People Who Inject Drugs Living with HIV/Hep C RFA

Janssen Therapeutics Request for Applications (RFA):

"Improving Care and Treatment for People Who Inject Drugs (PWID) Living with HIV and/or Hepatitis C"

Area of Interest

Comprehensive community-based models that enhance the ability of PWID living with HIV and/or HCV to access care and treatment

Eligible Applicants

501(c)(3) tax-exempt, community-based organizations in the US that work with PWID living with HIV and/or HCV

Amount 
One year charitable contribution of up to $40,000

Submission

November 25, 2014 - January 31, 2015 (Applications will be reviewed and funded on a rolling basis through early 2015)

Application

Applications must be submitted online through Janssen’s charitable contribution application system

Application Process

Please note: Applications will only be accepted via the Charitable Contributions portal. Educational grants will not be considered.

Visit www.janssentherapeutics-grants.com/contribution.html for more information or email questions to JT-RFGA@its.jnj.com .

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.